Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirokazu Matsushita

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
γδ T cell-based cancer immunotherapyHirokazu Matsushita, Kazuhiro Kakimi
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Dendritic cells for cancer immunotherapy]Kazuhiro Kakimi, Atsushi Kondo, Hirokazu Matsushita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2019
[Neoantigens Are Critical Targets in Naturally and Therapeutically Induced Immune Responses to Cancer]Hirokazu Matsushita, Ayako Demachi-Okamura, Yusuke Takahashi
Breast Cancer (Tokyo, Japan)|March 23, 2016
Advances in personalized cancer immunotherapyKazuhiro Kakimi, Takahiro Karasaki, Hirokazu Matsushita, et al.
Translational Lung Cancer Research|March 26, 2015
γδ T cell therapy for the treatment of non-small cell lung cancerKazuhiro Kakimi, Hirokazu Matsushita, Tomohiro Murakawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Identification of neoantigens and development of antigen-specific immunotherapy]Shuichi Shinohara, Yusuke Takahashi, Ayako Demachi-Okamura, et al.
Journal of Thoracic Disease|March 13, 2023
The beginning of a new era in induction treatment for operable non-small cell lung cancer: a narrative reviewShuichi Shinohara, Yusuke Takahashi, Katsuhiro Masago, et al.
Oncoimmunology|May 8, 2015
CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity: a few T cells can influence the growth of many times more tumor cellsKazuhiro Kakimi, Hirokazu Matsushita, Akihiro Hosoi, et al.
Virchows Archiv : an International Journal of Pathology|December 26, 2024
S100-positive stroma in salivary gland basal cell adenomas: a neoplastic component with CTNNB1 mutationsEiichi Sasaki, Yasuko Fujita, Katsuhiro Masago, et al.
Oncoimmunology|February 6, 2018
Dendritic cell vaccine induces antigen-specific CD8<sup>+</sup> T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockadeKoji Nagaoka, Akihiro Hosoi, Tamaki Iino, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
γδ T cell-based cancer immunotherapyHirokazu Matsushita, Kazuhiro Kakimi
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Dendritic cells for cancer immunotherapy]Kazuhiro Kakimi, Atsushi Kondo, Hirokazu Matsushita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2019
[Neoantigens Are Critical Targets in Naturally and Therapeutically Induced Immune Responses to Cancer]Hirokazu Matsushita, Ayako Demachi-Okamura, Yusuke Takahashi
Breast Cancer (Tokyo, Japan)|March 23, 2016
Advances in personalized cancer immunotherapyKazuhiro Kakimi, Takahiro Karasaki, Hirokazu Matsushita, et al.
Translational Lung Cancer Research|March 26, 2015
γδ T cell therapy for the treatment of non-small cell lung cancerKazuhiro Kakimi, Hirokazu Matsushita, Tomohiro Murakawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Identification of neoantigens and development of antigen-specific immunotherapy]Shuichi Shinohara, Yusuke Takahashi, Ayako Demachi-Okamura, et al.
Journal of Thoracic Disease|March 13, 2023
The beginning of a new era in induction treatment for operable non-small cell lung cancer: a narrative reviewShuichi Shinohara, Yusuke Takahashi, Katsuhiro Masago, et al.
Oncoimmunology|May 8, 2015
CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity: a few T cells can influence the growth of many times more tumor cellsKazuhiro Kakimi, Hirokazu Matsushita, Akihiro Hosoi, et al.
Virchows Archiv : an International Journal of Pathology|December 26, 2024
S100-positive stroma in salivary gland basal cell adenomas: a neoplastic component with CTNNB1 mutationsEiichi Sasaki, Yasuko Fujita, Katsuhiro Masago, et al.
Oncoimmunology|February 6, 2018
Dendritic cell vaccine induces antigen-specific CD8<sup>+</sup> T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockadeKoji Nagaoka, Akihiro Hosoi, Tamaki Iino, et al.
Pageof 10